19.25SEK+4.62%Mkt Cap: 364.76M SEKP/E: —Last update: 2026-06-01
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap364.76M SEK
Enterprise Value128.90M SEK
Revenue (TTM)11.81M SEK
Gross Profit-1.69M SEK
Net Income (TTM)-182.49M SEK
Revenue/Share1.090 SEK
Last Price19.25 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees73
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011527845
Valuation
P/E (Trailing)—
P/E (Forward)-61.33
PEG—
EV/EBITDA-0.84
EV/Revenue10.92
P/S29.53
P/B1.15
EPS (TTM)-9.08
EPS (Forward)-0.30
52W Range
14.557% of range79.00
52W High79.00 SEK
52W Low14.55 SEK
Profitability
Gross Margin-15.26%
Oper. Margin-1342.61%
EBITDA Margin0.00%
Profit Margin-1644.31%
ROE-53.99%
ROA-49.36%
Growth
Revenue Growth-57.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-162.12M SEK
CapEx (TTM)7.56M SEK
FCF Margin-785.16%
FCF Yield-25.41%
Net Debt-219.76M SEK
Net Debt/EBITDA1.44
Balance Sheet
Debt/Equity0.02
Current Ratio10.48
Quick Ratio9.31
Book Value/Sh16.07 SEK
Cash/Share11.82 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateJul 14, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.95M
Float11.66M
Insiders13.96%
Institutions25.37%
Technical
SMA 5019.74 (-2.5%)
SMA 20026.16 (-26.4%)
Beta0.54
S&P 52W Chg27.70%
Avg Vol (30d)13.37K
Avg Vol (10d)6.58K
Technical Indicators
RSI (14)52.0
MACD-0.4077
MACD Signal-0.8527
MACD Hist.+0.4450
BB Upper18.97 SEK
BB Middle16.84 SEK
BB Lower14.70 SEK
BB Width25.30%
ATR (14)1.127 SEK
Vol Ratio (20d)0.04x